Aurigene Pharmaceutical Services | FDA | Inspections | Form 483 | Warning Letters | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Aurigene Pharmaceutical Services
FDA

Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

Contact Supplier

Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Contact Supplier

pharmacompass-1-m-2026-01-12

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

Contact Supplier

pharmacompass-2-m-2025-11-03

Aurigene Pharmaceutical Services

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

VIDEO(s)

Corporate Video, Advanced Biologics CDMO Services, Drug Discovery with AI, Formulation Manufacturing Services, High-Potent Manufacturing, Message from Akhil Ravi, CEO, HPAPI Development and Manufacturing Services, Contract Manufacturing Services, Drug Discovery Services, Formulation Development Services, CDMO Services, Discovery Biology Service, Peptide Discovery, Development & Manufacturing Services

Corporate Video
Advanced Biologics CDMO Services
Drug Discovery with AI
Formulation Manufacturing Services
High-Potent Manufacturing
Message from Akhil Ravi, CEO
HPAPI Development and Manufacturing Services
Contract Manufacturing Services
Drug Discovery Services
Formulation Development Services
CDMO Services
Discovery Biology Service
Peptide Discovery, Development & Manufacturing Services

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 33 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
33 News #PharmaBuzz

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

SERVICES

API Manufacturing, Drug Product Manufacturing, API & Drug Product Development

API Manufacturing
Drug Product Manufacturing
API & Drug Product Development

INSPECTIONS & REGISTRATIONS

4 FDA

4 FDA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Legal Name Reset all filters

4 All

01 2Aurigene Pharmaceutical Services Limited

02 2Aurigene Pharmaceutical Services Ltd

filter District Decision Reset all filters

4 All

01 2No Action Indicated

02 2Voluntary Action Indicated

filter Inspection End Date Reset all filters

4 All

01 22019-03-21

02 22016-06-15

filter City Reset all filters

4 All

01 4Hyderabad

filter Country/Area Reset all filters

4 All

01 4India

Supplier Virtual Booth

price-trend

01

FDA Audited

USA

SCOPE Summit

Not Confirmed

FDA Audited

USA

SCOPE Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2019-03-21

Aurigene Pharmaceutical Services

City : Hyderabad

State :

Country/Area : India

Zip :

District :

Center :

Project Area : Bioresearch Monitoring

District Decision : No Action Indicated

Inspection End Date : 2019-03-21

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

FDA Audited

USA

SCOPE Summit

Not Confirmed

FDA Audited

USA

SCOPE Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2019-03-21

Aurigene Pharmaceutical Services

City : Hyderabad

State :

Country/Area : India

Zip :

District :

Center :

Project Area : Bioresearch Monitoring

District Decision : No Action Indicated

Inspection End Date : 2019-03-21

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

03

FDA Audited

USA

SCOPE Summit

Not Confirmed

FDA Audited

USA

SCOPE Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2016-06-15

Aurigene Pharmaceutical Services

City : Hyderabad

State :

Country/Area : India

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2016-06-15

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

04

FDA Audited

USA

SCOPE Summit

Not Confirmed

FDA Audited

USA

SCOPE Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2016-06-15

Aurigene Pharmaceutical Services

City : Hyderabad

State :

Country/Area : India

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2016-06-15

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.